Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Protective Role of Alpha Lipoic Acid Against Possible Cardiovascular Events in Patients With Haemodialysis

NCT03912727 is registered in ClinicalTrials.gov with Rehab Werida as lead sponsor.

NCT NCT03912727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03912727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Protective Role of Alpha Lipoic Acid Against Possible Cardiovascular Events in Patients With Haemodialysis
Lead sponsor
Rehab Werida
Phase
Not applicable
Overall status
Completed
Start date
April 11, 2019
Completion date
September 1, 2019
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis complication